Table 2 Baseline data profile by diet group
Variable | Control (n= 44) | Low fat (n= 50) | Low carb (n= 48) | P (Global Ftest) |
|---|---|---|---|---|
Age (years) | 56.61 ± 7.73 | 56.32 ± 8.08 | 55.19 ± 8.09 | 0.66 |
BMI | 29.13 ± 2.92 | 28.37 ± 2.43 | 29.47 ± 2.65 | 0.12 |
Weight (lb) | 175.53 ± 22.25 | 172.11 ± 18.54 | 176.74 ± 20.17 | 0.51 |
% Fat mass | 43.37 ± 5.63 | 42.31 ± 4.91 | 43.65 ± 4.86 | 0.39 |
Glucose | 83.60 ± 8.46 | 83.40 ± 9.22 | 86.33 ± 6.87 | 0.16 |
Cholesterol | 204.72 ± 31.55 | 204.08 ± 42.41 | 201.66 ± 31.92 | 0.91 |
Triglycerides | 133.28 ± 53.96 | 113.54 ± 58.72 | 139.13 ± 69.48 | 0.10 |
HDL | 59.49 ± 16.10 | 66.30 ± 18.56 | 61.28 ± 15.87 | 0.13 |
LDL | 118.53 ± 29.76 | 115.12 ± 37.56 | 112.57 ± 28.99 | 0.69 |
Chol/HDL ratio | 3.63 ± 0.97 | 3.28 ± 1.05 | 3.50 ± 1.08 | 0.25 |
Years since diagnosis | 5.43 ± 4.09 | 6.78 ± 6.21 | 8.40 ± 5.80 | 0.037 |
Stage 0 (%) | 9.1 | 12.0 | 4.2 | 0.38 |
Stage I (%) | 38.6 | 34.0 | 43.8 | 0.62 |
Stage IIA (%) | 22.7 | 28.0 | 27.1 | 0.73 |
Stage IIB (%) | 15.9 | 18.0 | 10.4 | 0.56 |
Stage IIIA (%) | 9.1 | 4.0 | 6.3 | 0.61 |
Stage IIIB (%) | 4.5 | 4.0 | 4.2 | 0.33 |
Stage IIIC (%) | 0.0 | 0.0 | 2.1 | 0.41 |
Chemotherapy (%) | 56.8 | 70.0 | 62.5 | 0.41 |
Hormonal therapy (%) | 77.3 | 82.0 | 77.1 | 0.80 |
Statins (%) | 15.9 | 18.0 | 20.8 | 0.83 |
Other cholesterol-lowering agents (%) | 2.3 | 2.0 | 2.1 | 0.33 |